Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Seizures: Classification01:13

Seizures: Classification

1.8K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.8K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.4K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

982
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
982
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

1.9K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.9K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.4K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.4K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

1.4K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.4K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

When measles is not benign: meningoencephalitis and status epilepticus in an unvaccinated adolescent (case report).

The Pan African medical journal·2026
Same author

Long-term CPAP treatment for OSA in pycnodysostosis: A 15-year longitudinal follow-up of a patient.

Respiratory medicine case reports·2026
Same author

Mechanical stress from the hyoid bone as a potential etiology of bony-related ischemic stroke secondary to carotid artery dissection: A case report and systematic review.

Radiology case reports·2026
Same author

Bony Stroke: Clinical Features, Management, and Outcomes in a Case Series of Seven Patients.

Cureus·2026
Same author

Face-mask CPAP as palliative support for diffuse tracheobronchomalacia from ring agenesis in an infant: When sleep becomes therapeutic.

Respiratory medicine case reports·2026
Same author

Pycnodysostosis and obstructive sleep apnea: Observations on 10 cases.

Respiratory medicine case reports·2025

Video Experimental Relacionado

Updated: Feb 21, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.7K

Accidentes cerebrovasculares y epilepsia vascular

Samira Er-Riouiche1, Asma El Tahiri1, Siham Bouchal1,2

  • 1Department of Neurology, Hassan II University Hospital, Fes, Morocco.

La Tunisie medicale
|February 19, 2026
PubMed
Resumen

El accidente cerebrovascular es una causa principal de epilepsia en adultos mayores, lo que aumenta el riesgo de convulsiones y afecta la recuperación. Esta revisión simplifica el manejo de la epilepsia vascular basándose en las recomendaciones de expertos, abordando los desafíos de las convulsiones post-accidente cerebrovascular en los pacientes.

Palabras clave:
Accidente cerebrovascularmedicamentos antiepilépticosconvulsión epiléptica tempranaepilepsia vascular

Más Videos Relacionados

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
09:16

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury

Published on: June 21, 2019

26.4K
Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
07:07

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

11.4K

Videos de Experimentos Relacionados

Last Updated: Feb 21, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.7K
Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
09:16

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury

Published on: June 21, 2019

26.4K
Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
07:07

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

11.4K

Área de la Ciencia:

  • Neurología; Geriatría; Epileptología

Sus antecedentes:

  • El accidente cerebrovascular (ACV) es una causa principal de epilepsia en los ancianos.
  • Las convulsiones post-accidente cerebrovascular deterioran significativamente la recuperación funcional y la calidad de vida.

Objetivo del estudio:

  • Aclarar y simplificar el manejo de la epilepsia vascular utilizando recomendaciones recientes de expertos.
  • Abordar los desafíos en la incidencia de convulsiones post-accidente cerebrovascular, las características clínicas y las necesidades terapéuticas.

Principales métodos:

  • Análisis de estudios existentes sobre subtipos de accidentes cerebrovasculares, momento de inicio de las convulsiones y factores de riesgo (edad, comorbilidades, gravedad del accidente cerebrovascular).
  • Inclusión de recomendaciones actuales de expertos para el manejo de la epilepsia vascular.

Principales resultados:

  • La incidencia de convulsiones varía según el subtipo de accidente cerebrovascular y el momento posterior al accidente.
  • Existe una falta de consenso sobre los factores de riesgo específicos y las estrategias de manejo óptimas.

Conclusiones:

  • Se necesitan directrices claras para el manejo de la epilepsia post-accidente cerebrovascular, particularmente en pacientes de edad avanzada de alto riesgo.
  • Las recomendaciones actuales ofrecen información, pero se requiere más investigación para refinar los factores de riesgo y el manejo.